- Home
- AMST vs CMND Comparison
AMST vs CMND Comparison
Compare AMST & CMND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AMST | CMND |
|---|---|---|
| Founded | N/A | 2017 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7M | 3.2M |
| IPO Year | 2020 | 2021 |
Fundamental Metrics
Financial Performance| Metric | AMST | CMND |
|---|---|---|
| Price | $0.54 | $5.85 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 31.0K | 8.8K |
| Earning Date | 11-17-2026 | 09-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 38.83 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $364,777.00 | N/A |
| Revenue This Year | $19,089.81 | N/A |
| Revenue Next Year | $22.86 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 230.24 | N/A |
| 52 Week Low | $0.52 | $0.07 |
| 52 Week High | $3.05 | $7.16 |
Technical Indicators
Market Signals| Indicator | AMST | CMND |
|---|---|---|
| Relative Strength Index (RSI) | 19.50 | 63.38 |
| Support Level | N/A | $0.66 |
| Resistance Level | $1.11 | $7.16 |
| Average True Range (ATR) | 0.06 | 0.32 |
| MACD | -0.00 | -0.19 |
| Stochastic Oscillator | 13.20 | 45.85 |
Price Performance
Historical ComparisonAbout AMST Amesite Inc.
Amesite Inc is a technology company focused on building and commercializing AI (artificial intelligence)-powered solutions for the enterprise and for professionals, with particular emphasis on the post-acute healthcare market. It operates through two product lines: NurseMagic and LynkMagic. NurseMagic solutions include a B2B (business-to-business) enterprise application and a B2C (business-to-consumer) solution for individual healthcare professionals. LynkMagic provides enterprise AI solutions for healthcare and related organizations. Its products support documentation, workflow, compliance, oversight, and are designed to improve operational quality and efficiency. It has one single operating and reporting segment, B2C and B2B AI-driven solutions.
About CMND Clearmind Medicine Inc.
Clearmind Medicine Inc is a clinical-stage pharmaceutical company engaged in Phase I/IIa clinical trials of novel psychedelic medicines. The Company focuses on developing treatments for mental health disorders, including alcohol use disorder (AUD), binge drinking, and eating disorders. Its activities are centered on the research and development of 5-methoxy-2-aminoindane (MEAI). It operates through a single research and development segment, which is conducted in Israel.